GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Murae Organisor Ltd (BOM:542724) » Definitions » Risk Assessment

Murae Organisor (BOM:542724) Risk Assessment


View and export this data going back to 2019. Start your Free Trial

What is Murae Organisor Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Murae Organisor is: High Risk: High uncertainty with risk-return tradeoff.


Competitive Comparison of Murae Organisor's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Murae Organisor's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Murae Organisor's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Murae Organisor's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Murae Organisor's Risk Assessment falls into.



Murae Organisor  (BOM:542724) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Murae Organisor Risk Assessment Related Terms

Thank you for viewing the detailed overview of Murae Organisor's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Murae Organisor (BOM:542724) Business Description

Traded in Other Exchanges
N/A
Address
Science City Road, A-1106, Empire Business Hub, Near Auda Water Tank, Sola, Ahmedabad, GJ, IND, 380060
Murae Organisor Ltd Formerly Earum Pharmaceuticals Ltd is engaged in the pharmaceutical business. It is involved in the marketing, trading, and distribution of a wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, dermatology products, cerebral activator drugs, neurological drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a wide range of pharmaceutical formulation products that are marketed under its brand name. Apart from pharmaceutical formulation products, the company also deals in the trading of active pharmaceutical ingredients.

Murae Organisor (BOM:542724) Headlines

No Headlines